CANADA-BASED · ANIMAL HEALTH RESEARCH

Animal health.
New possibilities.

Enter Vetalivo

Companion animals & livestock

A horse, calf, dog and pig in a green pasture
Companion animals

Improving health, supporting longevity and enhancing quality of life.

Livestock

Supporting animal health, lean muscle growth and efficient livestock production.

CANADA-BASED · ANIMAL HEALTH RESEARCH

Better animal health. Better quality of life.

We are developing novel vaccines and biologics to improve the health and quality of life of companion animals and livestock. Our research focuses on muscle health, chronic inflammation and unmet needs in veterinary medicine.

Investigational programs. Safety and effectiveness have not been established.

Explore our programs
Vetalivo Animal Health Inc.Ontario, Canada

COMPANY

Novel vaccines and biologics for livestock and companion animals

Vetalivo is an animal health company based in Ontario, Canada.

We are developing vaccines and other biologics with the goal of delivering safe, effective and affordable solutions for veterinary medicine, livestock production and animal welfare.

Our lead program focuses on preserving muscle and increasing lean muscle mass in swine. Our broader research includes approaches to chronic inflammatory diseases and muscle loss in companion animals.

BASEOntario, Canada
PURPOSEAnimal health & wellbeing
FOUNDATIONResearch & development

RESEARCH & PROGRAMS

Our vaccine programs

Research focused on muscle health, chronic inflammation and better quality of life for animals.

VA-400

Muscle preservation and lean muscle growth

Livestock and companion animals

INVESTIGATIONALInitial focus: swine

Muscle preservation during illness and recovery.

VA-400 is designed to target a protein that limits muscle growth, with the aim of preserving muscle, increasing lean muscle mass and reducing the fat-to-muscle ratio in livestock.

Our initial research explores whether VA-400 can reduce muscle loss and impaired weight gain associated with viral or bacterial infections in swine, including porcine reproductive and respiratory syndrome (PRRS). The aim is to support muscle preservation during illness and recovery.

We are also exploring VA-400’s potential to:

  • Help preserve muscle in companion animals affected by aging and frailty.
  • Help preserve lean muscle mass in companion animals with chronic conditions such as chronic kidney disease (CKD).

VA-202

Reducing chronic inflammatory diseases and supporting longevity

Companion animals

INVESTIGATIONALInflammatory conditions

Exploring potential veterinary applications.

VA-202 is being developed to address inflammatory conditions, with an initial focus on chronic kidney disease, arthritis and seizures in companion animals. It is designed to inhibit excessive inflammatory activity that may contribute to inflammatory diseases or be associated with seizures in dogs.

Potential applications in other inflammatory conditions, including atopic dermatitis, are also being explored.

VA-400 and VA-202 are investigational vaccines. Safety and effectiveness have not been established. They are not available as products or services.

MISSION & COLLABORATION

Focused on unmet needs

To improve animal health and quality of life through novel vaccines and biologics that address unmet needs in companion animals and livestock.

Work with us

We welcome discussions with researchers, veterinarians and industry partners interested in advancing our programs or exploring new applications for our technology.

Discuss a collaboration

CONTACT

Let’s advance
the conversation.

Contact us to discuss research, veterinary development or partnership opportunities.

VETALIVO ANIMAL HEALTH INC.

Ontario
Canada

Business address

7030 Woodbine Ave, Suite 500
Markham, ON L3R 6G2
Canada

bd@vetalivo.com

Research, veterinary development and partnership enquiries.